TNON
Tenon Medical, Inc.Company with tickers: TNON, TNONW
CIK
1560293
CUSIP
88066N303
Shares Outstanding
11,573,428
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,379,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $434,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | $945,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $4,225,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $662,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-3,280,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-3,476,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.31 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $0.31 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |